Source comparison
Mechanism Comparison — Suppression vs Regeneration
Cortisone injections (typically triamcinolone or methylprednisolone) work by binding glucocorticoid receptors in immune cells, blocking phospholipase A2. The enzyme that converts arachidonic acid into prostaglandins and leukotrienes, the mediators of inflammat
This comparison does not assign a generated winner or score.
- Cortisone injections (typically triamcinolone or methylprednisolone) work by binding glucocorticoid receptors in immune cells, blocking phospholipase A2. The enzyme that converts arachidonic acid into prostaglandins and leukotrienes, the mediators of inflammation. Pain relief occurs within 24–72 hours because the inflammatory cascade halts. The trade-off: glucocorticoids simultaneously inhibit fibroblast activity, reduce collagen synthesis by 30–50% in treated tissue, and trigger localized catabolic effects that weaken tendon structure with repeated use. A 2019 systematic review in the British Journal of Sports Medicine found cortisone injections for lateral epicondylitis produced worse long-term outcomes than placebo at 12 months. Short-term gain, long-term structural cost.
- BPC-157 operates through angiogenic and mitogenic pathways. It upregulates VEGF receptor expression, stimulating endothelial cell migration and new blood vessel formation at injury sites. Crucial for delivering oxygen and nutrients to hypoxic damaged tissue. Simultaneously, it promotes fibroblast chemotaxis (directional migration toward injury) and increases synthesis of type I collagen, the primary structural protein in tendons and ligaments. Animal studies demonstrate BPC-157 accelerates healing timelines: rat Achilles tendon transections treated with BPC-157 showed 60% greater tensile strength at 14 days post-injury compared to controls. The mechanism isn't anti-inflammatory. It's pro-repair. Inflammation may persist longer, but tissue integrity improves measurably.
- The biological logic: cortisone treats the symptom (pain) by removing the signal (inflammation). BPC-157 addresses the deficit (damaged tissue) by accelerating the repair process (collagen deposition, vascularization). Neither is universally superior. Context determines which mechanism serves the injury better. Acute inflammation in a structurally sound joint (e.g., reactive bursitis) responds to cortisone. Chronic tendinopathy with collagen degradation doesn't.